BioSpace News Archive

Deals

TransEnterix Schedules First Quarter Financial and Operating Results Conference Call for May 9, 2019

TransEnterix, Inc. announced that it plans to release first quarter financial and operating results after the market closes on Thursday, May 9, 2019.

April 24, 2019
·
1 min read
Biotech Bay

Spark Therapeutics CEO and Former Merck President to Keynote Veeva Commercial & Medical Summit

Industry leaders to discuss the impact of advanced innovation on commercial models and driving improved patient outcomes

April 24, 2019
·
4 min read
Drug Development

Cavion to Present Results of Phase 2 Essential Tremor Clinical Trial in Platform Presentation at the American Academy of Neurology

Presentation to provide overview of Phase 2 T-CALM study design, results and clinical path forward

April 24, 2019
·
3 min read
Deals

MDxHealth provides Q1 2019 business update

MDxHealth SA, a commercial-stage innovative molecular diagnostics company, provided a business update for the first quarter ended March 31, 2019.

April 24, 2019
·
5 min read
Bio NC

Survey: Women 18 to 44 Years Say Safety is Most Important Factor when Choosing a Hospital for Labor and Delivery

Nine out of ten mothers in peak childbearing years say technology to protect women and babies during L&D would influence decision about where to give birth

April 24, 2019
·
4 min read
BioForest

LightIntegra Raises $5.3 Million USD in Series A Funding to Introduce ThromboLUX Test for Blood Platelet Activation Status to US Market

Medical Diagnostics Company Aims to Improve Efficacy of Platelet Transfusions

April 24, 2019
·
2 min read
Volpara Health Technologies Secures Medical Device Single Audit Program (MDSAP) 690110 Certification

MDSAP Certification Satisfies ISO and Regulatory Compliance Requirements for Japan, Australia, Canada, and the United States

April 24, 2019
·
3 min read
Deals

Bausch Health Companies Announces Participation In Upcoming Investor Conferences - April 24, 2019

Bausch Health Companies Inc. announced that the Company will participate in four investor conferences in May.

April 24, 2019
·
1 min read
Biotech Bay

Reducing care needs of teens with substance-abuse disorders

Kaiser Permanente researchers find long-term benefits for patients and health organizations that employ screenings, interventions, and referrals

April 24, 2019
·
4 min read
Drug Development

Rexgenero Presents Update on Phase III Clinical Trials with REX-001, a Cell-based Therapy for Critical Limb Ischaemia

At the Alliance for Regenerative Medicine’s Cell and Gene Therapy ‘Meeting on the Med’ in Barcelona

April 24, 2019
·
4 min read